Strategic Transition Target RWE has restructured into Pedestal Health and Headwater Science under Highlander Health, presenting a unified opportunity to engage through the new brand entities and maintain continuity with existing contacts.

Evidence Platform Pedestal Health specializes in integrated evidence generation across hepatology, dermatology, and gastroenterology with embedded sites and longitudinal cohorts, offering a compelling value proposition for sponsors seeking real-world data and continual evidence across R&D, approval, and commercialization.

Strategic Roles Recent leadership appointment of Alan Brookhart as President of NoviSci signals potential expansion in real-world evidence platforms and analytics collaborations, presenting a doorway for partnerships, pilot studies, or co-developed study designs.

Tech & Compliance Adoption of a diversified tech stack (OneTrust, GitLab, Smartsheet, Contentful, Clarity, and more) points to strong data governance, collaboration, and automation capabilities that can support scalable study designs, regulatory submissions, and payer/HTA interactions.

Growth & Funding Revenue range and modest funding indicate a growing, mid-market player with potential for scale through expanded services, collaborations with larger CROs or pharma firms, and inclusion in broader open-access evidence networks.